Page last updated: 2024-09-05

n(4)-hydroxycytidine and Respiratory Syndrome, Acute, Severe

n(4)-hydroxycytidine has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnard, DL; Burton, J; Hubbard, VD; Morrey, JD; Otto, MJ; Sidwell, RW; Smee, DF1

Other Studies

1 other study(ies) available for n(4)-hydroxycytidine and Respiratory Syndrome, Acute, Severe

ArticleYear
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.
    Antiviral chemistry & chemotherapy, 2004, Volume: 15, Issue:1

    Topics: Animals; Chlorocebus aethiops; Cytidine; Glycoproteins; Molecular Structure; Nucleosides; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vero Cells; Virus Replication

2004